Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FB849 |
Trade Name | |
Synonyms | FB-849|FB 849 |
Drug Descriptions |
FB849 inhibits HPK1, which potentially results in increased antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200282 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FB849 | FB849 | 0 | 1 |
FB849 + Pembrolizumab | FB849 Pembrolizumab | 0 | 1 |